학술논문
Clinical and economic benefits of lenzilumab plus standard of care compared with standard of care alone for the treatment of hospitalized patients with COVID-19 in the United States from the hospital perspective
Document Type
Article
Author
Source
In: Journal of Medical Economics . (Journal of Medical Economics, 2022, 25(1):160-171)
Subject
Language
English
ISSN
1941837X
13696998
13696998